Article Details
Retrieved on: 2018-03-18 16:00:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>MIT bioengineers have developed a new microfluidic platform technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans. The microfluidic platform can connect 3D tissues from up to 10 organs. Replacing animal testing, it can accurately replicate human-organ interactions for weeks at a time [...]</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here